Paper19817543
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ and 8 others. J Neurosurg, 2010. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. Papers, record 19817543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19817543
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioblastoma | Major topic |
| Gliosarcoma | Major topic |
| Adult | |
| Aged | |
| Antineoplastic Agents | |
| Combined Modality Therapy | |
| Dacarbazine | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Temozolomide |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41569728 | Distal noncontiguous recurrence and sarcomatous transformation of glioblastoma with stable molecular profile: illustrative case. | J Neurosurg Case Lessons | 2026 | https://conductscience.org/library/papers/41569728 | PubMed |
| 40612823 | A Challenging Diagnosis of Gliosarcoma: A Case Report. | Cureus | 2025 | https://conductscience.org/library/papers/40612823 | PubMed |
| 40151286 | A rare case of gliosarcoma: Comprehensive radiological, histopathological, and clinical insights into diagnosis and management. | Radiol Case Rep | 2025 | https://conductscience.org/library/papers/40151286 | PubMed |
| 36798692 | Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature. | Front Oncol | 2022 | https://conductscience.org/library/papers/36798692 | PubMed |
| 32440565 | Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. | Bioeng Transl Med | 2020 | https://conductscience.org/library/papers/32440565 | PubMed |
| 32393192 | Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report. | BMC Neurol | 2020 | https://conductscience.org/library/papers/32393192 | PubMed |
| 31921679 | Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31921679 | PubMed |
| 29682024 | Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients. | Asian J Neurosurg | 2018 | https://conductscience.org/library/papers/29682024 | PubMed |
| 28904651 | [Primary cerebral gliosarcoma: about two cases and review of the literature]. | Pan Afr Med J | 2017 | https://conductscience.org/library/papers/28904651 | PubMed |
| 28290000 | Glioblastoma recurrence, progression, and dissemination as a purely subdural gliosarcoma. | J Neurooncol | 2017 | https://conductscience.org/library/papers/28290000 | PubMed |
| 27699141 | Post-Treatment Gliosarcoma Extension into the Pterygomaxillary Fossa: Literature Review and Case Report. | Cureus | 2016 | https://conductscience.org/library/papers/27699141 | PubMed |
| 27025857 | Radiotherapy plus concomitant temozolomide in primary gliosarcoma. | J Neurooncol | 2016 | https://conductscience.org/library/papers/27025857 | PubMed |
| 26725096 | Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients. | J Neurooncol | 2016 | https://conductscience.org/library/papers/26725096 | PubMed |
| 26621904 | Gliosarcoma with neuroaxis metastases. | BMJ Case Rep | 2015 | https://conductscience.org/library/papers/26621904 | PubMed |
| 26354773 | Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. | J Neurooncol | 2015 | https://conductscience.org/library/papers/26354773 | PubMed |
| 25905568 | Therapeutic management of gliosarcoma in the temozolomide era. | CNS Oncol | 2015 | https://conductscience.org/library/papers/25905568 | PubMed |
| 24355182 | Primary gliosarcoma of the brain: radiologic and histopathologic features. | Neuroradiol J | 2013 | https://conductscience.org/library/papers/24355182 | PubMed |
| 23324827 | Genetic and pathologic evolution of early secondary gliosarcoma. | Brain Tumor Pathol | 2014 | https://conductscience.org/library/papers/23324827 | PubMed |
| 23266723 | Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. | J Neurooncol | 2013 | https://conductscience.org/library/papers/23266723 | PubMed |
| 23237552 | On the origin of cancer metastasis. | Crit Rev Oncog | 2013 | https://conductscience.org/library/papers/23237552 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19817543
GET https://conductscience.org/api/papers/v1/19817543/cited_by?page=2